Jean‐Paul Joly

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

Julien Edeline, M. Benabdelghani, Aurélie Bertaut et al. · Journal of Clinical Oncology · 2019 · 504 citations

Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.

Julien Edeline, Franck Bonnetain, Jean–Marc Phelip et al. · Journal of Clinical Oncology · 2017 · 110 citations

Surgical Oncology, Cancer Management, Gastroenterology +23

BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma

Antoine Galmiche, Zakaria Ezzoukhry, Catherine François et al. · Molecular Cancer Research · 2010 · 48 citations

Bcl2 Family, Apoptosis, Pathology +17

Management of patients with carcinoma of the right colon invading the duodenum or pancreatic head

David Fuks, Patrick Pessaux, Jean‐Jacques Tuech et al. · International Journal of Colorectal Disease · 2008 · 47 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +11

Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice

David Fuks, Éric Bartoli, Richard Delcenserie et al. · Journal of Gastroenterology and Hepatology · 2009 · 41 citations